CYTOLAB MEDYCZNE LABORATORIUM DIAGNOSTYCZNE EDYTA KRUZEL-SZWACZKA SPÓŁKA KOMANDYTOWA

CYTOLAB MEDYCZNE LABORATORIUM DIAGNOSTYCZNE EDYTA KRUZEL-SZWACZKA SPÓŁKA KOMANDYTOWA

Copy
copy info iconCopy

Key data

Status

Active

KRS number

0001069242Copy
copy info iconCopy

REGON

52694694500000Copy
copy info iconCopy

NIP/VAT code

6343031629Copy
copy info iconCopy

VAT registration date

01/04/2024

VAT status

Exempt

Bankruptcy proceedings

No proceedings

CYTOLAB MEDYCZNE LABORATORIUM DIAGNOSTYCZNE EDYTA KRUZEL-SZWACZKA SPÓŁKA KOMANDYTOWA

Contacts

Registered address

Registered address

UL. MIKOŁOWSKA 53, 40-065, KATOWICE, POLSKACopy
copy info iconCopy
See on map
Website

Website

-
None Pie Chart
no data iconNot calculated
Highest reliabilityLowest reliability

Reliability

A - Highest
B - High
C - Average
D - Low
E - Lowest
alter icon

Prescore cannot be calculated – need expert evaluation.

Incorporation date

15/11/2023

Share capital

No data

Primary activity

Other human health activities notelsewhere classified (86.90.E - PKD 2007)

Representatives

0

Representatives rights

KAŻDY WSPÓLNIK UPRAWNIONY DO REPREZENTACJI SPÓŁKI MA PRAWO REPREZENTOWAĆ SPÓŁKĘ SAMODZIELNIE.

Representatives

blue dotNo representatives

Business linkages

Price: zł63.00
Premium users: 1.00 credit

Financial report (Okredo)

Price: zł22.00
Premium users: 1.00 credit

People

Representatives

0
Personsort default icon
Titlesort default icon
-
-

Persons with Significant Control

0
psc login icon

Persons with Significant Control

This information is available in our reports and to subscription users.

Financial ratios

€

Net Profit (zł)

204,947

Net Profit (zł)

204,947

Financial report (Okredo)

Price: zł22.00
Premium users: 1.00 credit
Indicator
Turnover (zł)
Profit before tax (zł)
Net Profit (zł)
Working capital requirement (%)
info iconThe working capital requirement indicator shows how much funds a company needs to develop and maintain a business.
Liquidity ratio
info iconliquidityRatio
Net profitability (%)
info iconThis ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales.
Equity (zł)
Current liabilities (zł)
Non current liabilities (zł)
Non-current Assets (zł)
2024
976,178
225,618
204,947
0.31
4.07
20.99
405,047
97,709
48,603
154,096
2024
976,178
225,618
204,947
0.31
4.07
20.99
405,047
97,709
48,603
154,096

Turnover (zł)

2024

Turnover (zł)

976,178 złAscended- *

Profit before tax (zł)

225,618 złAscended- *

Net Profit (zł)

204,947 złAscended- *

Working capital requirement (%)

0.31 Ascended- *

Liquidity ratio

4.07 Ascended- *

Net profitability (%)

20.99 %Ascended- *

Equity (zł)

405,047 złAscended- *

Current liabilities (zł)

97,709 złAscended- *

Non current liabilities (zł)

48,603 złAscended- *

Non-current Assets (zł)

154,096 złAscended- *

*over the last year starting selected period

Credit history

No. of unpaid debts

0

Largest debt

-

Amount of unpaid debts

€0.00

Oldest open debt

-

No. of unpaid debts

0

Largest debt

-

Amount of unpaid debts

€0.00

Oldest open debt

-

Credit report

Price: 1.00 credit
Unpaid debts
locked icon
Creditor/Data sourcesort default icon
Debt amountsort default icon
Debt datesort default icon
Debt typesort default icon
-
-
-
-
Debt payment history
locked icon
Creditor/Data sourcesort default icon
Debt amountsort default icon
Debt datesort default icon
Payment datesort default icon
Debt typesort default icon
-
-
-
-
-

Documents

CYTOLAB MEDYCZNE LABORATORIUM DIAGNOSTYCZNE EDYTA KRUZEL-SZWACZKA SPÓŁKA KOMANDYTOWA Documents

1
Datesort default icon
Descriptionsort default icon
27/06/2025
OD 15.11.2023 DO 31.12.2024